BioGaia® Gastrus® Probiotic Lactobacillus reuteri (DSM 17938 ATCC PTA 6475) 200 million organisms (CFU) Targeted support with this unique Lactobacillus reuteri strain combination Clinically trialed probiotic combination Contains only probiotic strains of human origin: Lactobacillus reuteri DSM 17938 Lactobacillus reuteri ATCC PTA 6475 (both strains isolated from breast milk) Provides evidence-based probiotic strains with clinical data to support their use Delivers probiotic strains that survive transit through gastrointestinal (GI) tract without significant loss of potency (CFSs) Contains two probiotic strains shown to colonise the GI tract and adhere strongly to mucosal layer Delivers a scientifically validated daily dose of 200 million organisms (CFSs) in a convenient one-a-day dose Does not require refrigeration, for ease of use and dispensing Active Ingredients / Formulation Each chewable tablet contains: Lactobacillus reuteri (DSM 17938)……………………………100Mill* Lactobacillus reuteri (ATCC PTA 6475)……………………..100Mill* *CFU = Colony-Forming Units of Live Bacteria Directions Adults and children Take 1 chewable tablet daily, with or without food, or as directed by your prescribing healthcare practitioner. Ingredients (Protectis Chewable Tablets) Ingredients: Lactobacillus reuteri DSM 17938, Lactobacillus reuteri ATCC PTA 6475, isomalt, hydrogenated palm oil, ascorbic acid, mandarin flavour, mint flavour. No Added: Wheat | Yeast | Soy | Dairy | Animal products | Lactose | Egg | Nuts | Artificial colours, flavours, or preservatives. Suitable for vegetarians and vegans. Disclaimer For practitioner dispensing only. Always read the label. Follow the directions for use. Note Limosilactobacillus reuteri is a synonym for Lactobacillus reuteri
